SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-008707
Filing Date
2022-03-02
Accepted
2022-03-02 18:47:28
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3996
  Complete submission text file 0000899243-22-008707.txt   5393
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Tamboli Ajim (Reporting) CIK: 0001855684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40522 | Film No.: 22705770